Company Profile

Levisonics Inc
Profile last edited on: 1/18/2021      CAGE: 7VR81      UEI: GFC8EGJU6VZ5

Business Identifier: Blood coagulation analysis and fluid rheological measurement: drop-of-blood analysis
Year Founded
2016
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1441 Canal Street
New Orleans, LA 70112
   (504) 247-1587
   info@levisonics.com
   www.levisonics.com
Location: Single
Congr. District: 02
County: Orleans Parish

Public Profile

Coming out of a collaboration between Boston University and Tulane, Levisonics Inc. is organized around the development of new techniques for blood coagulation analysis and fluid rheological measurement: a novel method for assessment of whole blood or blood plasma coagulation, The firm’s proprietary technology platform is acoustic tweezing rheometry, a unique containerless approach for fluid analysis that uses only one drop of fluid sample per test: a drop-of-blood point-of-care coagulation analyzer capable of providing comprehensive diagnostic information about bleeding / thrombotic risks. The advantages of small sample size, non-contact, and rapid measurement make the technology especially useful for real-time monitoring of blood coagulation in the acutely unwell, trauma patients, those having undergone major surgery, and patients with coagulation disorders.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NSF $1,223,857
Project Title: Innovative Platform for Low Volume Blood Coagulation Analysis
2021 1 NIH $225,177
Project Title: Drop-of-blood technology for home-use monitoring of anticoagulant therapy

Key People / Management

  Phillip A Anderson -- Head of Engineering Development

  Glynn Holt -- Co-Founder and CTO

  Damir B Khismatullin -- CSO

  Daishan (Kevin) Luo

Company News

There are no news available.